Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - CAPITAL EXPENDITURES
Capital Expenditures OCUL - Ocular Therapeutix, Inc.
-6.09 M
LAST VALUE
-125.79%
2 YEAR CAGR
-26.37%
5 YEAR CAGR
-31.73%
10 YEAR CAGR